Opportunity Information: Apply for RFA CA 13 010
Apply for RFA CA 13 010
- The National Institutes of Health in the education health sector is offering a public funding opportunity titled "Sub Saharan African Collaborative HIV and Cancer Consortia (U54)" and is now available to receive applicants.
- Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.393 Cancer Cause and Prevention Research 93.394 Cancer Detection and Diagnosis Research 93.395 Cancer Treatment Research 93.396 Cancer Biology Research 93.399 Cancer Control 93.989 International Research and Research Training.
- This funding opportunity was created on Dec 18, 2013 and posted on Oct 25, 2013.
- Applicants must submit their applications by Jan 27, 2014. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
- Each selected applicant is eligible to receive up to $750,000.00 in funding.
- Eligible applicants include: State governments Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education Others (see text field entitled Additional Information on Eligibility for clarification) Public and State controlled institutions of higher education Private institutions of higher education Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education.
- Other Eligible Applicants include the following Alaska Native and Native Hawaiian Serving Institutions Asian American Native American Pacific Islander Serving Institutions (AANAPISISs) Hispanic serving Institutions Historically Black Colleges and Universities (HBCUs) Non domestic (non U.S.) Entities (Foreign Organizations) Tribally Controlled Colleges and Universities (TCCUs) Non domestic (non U.S.) Entities (Foreign Institutions) are eligible to apply, but only if they are located in sub Saharan African countries. Non domestic (non U.S.) components of U.S. Organizations are eligible to apply, without geographical restrictions. Foreign components, as defined in the NIH Grants Policy Statement, are allowed, without geographical restrictions.
[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:
Opportunity Summary:
The Sub Saharan African Collaborative HIV and Cancer Consortia (U54) opportunity (Funding Opportunity Number RFA-CA-13-010) is a National Institutes of Health (NIH) cooperative agreement designed to strengthen and expand research on HIV-associated cancers in sub-Saharan Africa through structured, long-term collaboration between institutions and investigators based in the United States and those based in sub-Saharan African countries. The central idea is to build consortia that can tackle cancer problems that are especially urgent in African settings where HIV is prevalent, while also building local research capacity and creating durable partnerships that can keep producing impactful science beyond the life of a single project.
This FOA supports applications for Specialized Center Cooperative Agreements (U54), which means awardees should expect an active partnership with NIH program staff rather than a hands-off grant mechanism. The consortium model is intended to bring multiple related projects under one coordinated umbrella, so the whole is stronger than any single study alone. Applications must include two to four linked research projects that address high-priority questions relevant to the participating African country or countries. The scope is intentionally broad: projects can range from basic laboratory science to translational research, as well as population-based, epidemiologic, and implementation-focused studies that look at how to deliver effective cancer prevention, screening, diagnosis, or care in real-world settings. At the same time, the announcement clearly states that clinical trials will not be supported under this FOA, so applicants need to design studies that stop short of interventional clinical trial activity while still producing actionable evidence.
A defining feature of the program is its required infrastructure, built through two mandatory cores that every application must include. First, an Administrative/Coordinating Core is required to manage the consortium, keep the projects aligned, coordinate communications and data/resource sharing, handle regulatory and operational logistics, and generally ensure that the collaboration functions smoothly across institutions and countries. Second, a Mentoring/Career Development Core is required to cultivate the next generation of researchers, with an emphasis on training and mentorship that strengthens scientific leadership and research independence, particularly in the African partner institutions. Applicants may also propose additional cores when they are justified by the scientific needs of the projects, such as shared technical resource cores (for example, pathology support, biostatistics, informatics, specimen processing, or other centralized capabilities that multiple projects will use). The expectation is that these shared resources will improve efficiency, standardize methods, and raise the overall quality and reproducibility of the consortiums work.
In terms of eligible applicants, the FOA is open to a wide range of organizations, including public and private institutions of higher education, state governments, and nonprofit organizations (both those with and without 501(c)(3) status), as well as other eligible entities described in the full announcement. The eligibility language explicitly includes several types of minority-serving institutions and tribally controlled institutions (such as HBCUs, Hispanic-serving institutions, AANAPISIs, and TCCUs). Importantly, foreign organizations are eligible to apply if they are located in sub-Saharan African countries, reflecting the program goal of centering African institutional participation rather than treating it as purely a subcontracting role. In addition, non-U.S. components of U.S. organizations may apply without geographic restriction, and foreign components as defined by NIH policy are allowed.
Administratively, the opportunity is categorized as a discretionary funding program using a cooperative agreement instrument, and it sits within NIH activity areas spanning cancer biology, prevention, detection/diagnosis, treatment research, and cancer control, along with international research and research training (CFDA numbers listed include 93.393, 93.394, 93.395, 93.396, 93.399, and 93.989). The posted date for the announcement was October 25, 2013, with an original application due date of January 17, 2014, later extended to January 27, 2014. The award ceiling is listed as $750,000, and there is no cost sharing or matching requirement, which can make budgeting more straightforward for consortia that need to support cross-site coordination, training activities, and shared research infrastructure.
Overall, this FOA is aimed at creating well-coordinated, multi-project research centers that can answer pressing questions about HIV-associated cancers in sub-Saharan Africa while simultaneously developing sustainable research capacity through formal coordination structures and strong mentoring and career development. It is not simply a call for isolated studies; it is a call to build an integrated research and training ecosystem that can produce high-quality evidence relevant to local needs and strengthen the long-term ability of African and U.S. partners to address the intersecting burdens of HIV and cancer.
Frequently Asked Questions (FAQs)
What is the Sub Saharan African Collaborative HIV and Cancer Consortia (U54) opportunity?
It is an NIH cooperative agreement opportunity (U54) intended to strengthen and expand research on HIV-associated cancers in sub-Saharan Africa by supporting structured, long-term collaboration between U.S.-based and sub-Saharan Africa-based institutions and investigators.
What is the Funding Opportunity Number (FON) for this announcement?
The Funding Opportunity Number is RFA-CA-13-010.
What is the primary goal of this funding opportunity?
The goal is to create collaborative, multi-project consortia that address high-priority HIV-associated cancer research questions that are especially urgent in sub-Saharan African settings, while also building local research capacity and durable institutional partnerships.
What funding mechanism is used?
This opportunity supports Specialized Center Cooperative Agreements (U54).
What does it mean that this is a cooperative agreement?
A cooperative agreement indicates an active partnership with NIH program staff. Awardees should expect NIH involvement in the program rather than a hands-off relationship typical of some other grant mechanisms.
What type of program structure does NIH expect under this FOA?
NIH expects an integrated consortium model where multiple related projects operate under a coordinated umbrella so that the combined program is stronger than any single study on its own.
How many research projects must be included in an application?
Applications must include two to four linked research projects.
What kinds of research are considered within scope?
The scope is broad and can include basic laboratory science, translational research, population-based studies, epidemiologic research, and implementation-focused studies that examine how to deliver effective cancer prevention, screening, diagnosis, or care in real-world settings.
Are clinical trials allowed under this FOA?
No. The announcement states that clinical trials will not be supported under this FOA, so projects should be designed to avoid interventional clinical trial activity while still producing actionable evidence.
What are the required cores for every application?
Every application must include two mandatory cores: (1) an Administrative/Coordinating Core and (2) a Mentoring/Career Development Core.
What is the purpose of the Administrative/Coordinating Core?
This core manages the consortium and helps keep projects aligned. It coordinates communication and data/resource sharing, handles regulatory and operational logistics, and supports smooth collaboration across institutions and countries.
What is the purpose of the Mentoring/Career Development Core?
This core is meant to cultivate the next generation of researchers through training and mentorship, with an emphasis on strengthening scientific leadership and research independence, particularly within the African partner institutions.
Can applicants propose additional cores beyond the two required cores?
Yes. Additional cores may be proposed when justified by the scientific needs of the projects.
What are examples of optional additional cores mentioned in the announcement?
Examples include shared technical resource cores such as pathology support, biostatistics, informatics, specimen processing, or other centralized capabilities used by multiple projects.
Why does the FOA emphasize shared resources and cores?
Shared resources are expected to improve efficiency, standardize methods, and raise overall quality and reproducibility across the consortium's work.
Who is eligible to apply for this opportunity?
The FOA is open to a wide range of organizations, including public and private institutions of higher education, state governments, and nonprofit organizations (with or without 501(c)(3) status), as well as other eligible entities described in the full announcement.
Are minority-serving and tribally controlled institutions explicitly included in eligibility?
Yes. The eligibility language explicitly includes several types of minority-serving and tribally controlled institutions, such as HBCUs, Hispanic-serving institutions, AANAPISIs, and TCCUs.
Are foreign organizations eligible to apply?
Yes. Foreign organizations located in sub-Saharan African countries are eligible to apply, consistent with the program's goal of centering African institutional participation.
Can non-U.S. components of U.S. organizations apply?
Yes. Non-U.S. components of U.S. organizations may apply without geographic restriction, and foreign components (as defined by NIH policy) are allowed.
What areas of research does this opportunity cover?
The opportunity sits within NIH activity areas spanning cancer biology, prevention, detection/diagnosis, treatment research, and cancer control, along with international research and research training.
What CFDA numbers are associated with this opportunity?
The CFDA numbers listed include 93.393, 93.394, 93.395, 93.396, 93.399, and 93.989.
When was the announcement posted?
The posted date was October 25, 2013.
What was the application due date?
The original application due date was January 17, 2014, and it was later extended to January 27, 2014.
What is the award ceiling for this FOA?
The award ceiling is listed as $750,000.
Is cost sharing or matching required?
No. There is no cost sharing or matching requirement stated for this opportunity.
What is NIH trying to build through this FOA beyond individual studies?
NIH is aiming to build coordinated, multi-project research centers that generate locally relevant evidence on HIV-associated cancers and strengthen long-term research capacity through formal coordination and strong mentoring and career development.
What is the overall emphasis of the consortium model in this FOA?
The emphasis is on durable partnerships and an integrated research and training ecosystem that can continue producing impactful science beyond the life of a single project.
Browse more opportunities from the same category: Education Health
Next opportunity: RFI Building Technologies Office Prioritization Tool
Previous opportunity: DoD Clinical and Rehabilitative Medicine Neuromusculoskeletal Injuries Research Award
USGrants.org Applicant Portal:
Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.
Apply for RFA CA 13 010
[Watch] how do funding administrators access proposals?
Applicants also applied for:
Applicants who have applied for this opportunity (RFA CA 13 010) also looked into and applied for these:
| Funding Opportunity |
|---|
| FY 2014 American Schools and Hospitals Abroad (ASHA) Program Apply for APS ASHA 14 000001 Funding Number: APS ASHA 14 000001 Agency: Agency for International Development Category: Education Health Funding Amount: $2,000,000 |
| Cancer Detection, Diagnostic and Treatment Technologies for Global Health (UH2/UH3) Apply for RFA CA 13 015 Funding Number: RFA CA 13 015 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Population based Research Optimizing Screening through Personalized Regimens (PROSPR) Revision to Enhance the Collection of Cervical Cancer Screening Data (U54) Apply for RFA CA 14 001 Funding Number: RFA CA 14 001 Agency: National Institutes of Health Category: Education Health Funding Amount: $650,000 |
| Cancer Center Support Grants (CCSGs) for NCI designated Cancer Centers (P30) Apply for PAR 13 386 Funding Number: PAR 13 386 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Low Cost, Pragmatic, Patient Centered Randomized Controlled Intervention Trials (UH2/UH3) Apply for RFA HL 14 019 Funding Number: RFA HL 14 019 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Development of Opioid and Adjuvant Fixed Combination Dosage Forms for the Treatment of Chronic Pain with Reduced Addiction Potential (R41/R42) Apply for PA 13 388 Funding Number: PA 13 388 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Development of Opioid and Adjuvant Fixed Combination Dosage Forms for the Treatment of Chronic Pain with Reduced Addiction Potential (R43/R44) Apply for PA 13 387 Funding Number: PA 13 387 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| NCI Community Oncology Research Program(NCORP) Community Sites (UM1) Apply for RFA CA 13 013 Funding Number: RFA CA 13 013 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| NCI Community Oncology Research Program (NCORP) Research Bases (UM1) Apply for RFA CA 13 012 Funding Number: RFA CA 13 012 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| NCI Community Oncology Research Program (NCORP) Minority/Underserved Community Sites (UM1) Apply for RFA CA 13 014 Funding Number: RFA CA 13 014 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Exceptional Unconventional Research Enabling Knowledge Acceleration (EUREKA) for Neuroscience and Disorders of the Nervous System (R01) Apply for RFA MH 14 214 Funding Number: RFA MH 14 214 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Indo US Collaborative Program on Affordable Medical Devices (R03) Apply for PAR 13 390 Funding Number: PAR 13 390 Agency: National Institutes of Health Category: Education Health Funding Amount: $75,000 |
| NCI Small Grants Program for Cancer Research (NCI Omnibus R03) Apply for PAR 14 007 Funding Number: PAR 14 007 Agency: National Institutes of Health Category: Education Health Funding Amount: $50,000 |
| Identification of Gene Variants for Addiction Related Traits by Next Gen Sequencing in Model Organisms Selectively Bred for Addiction Traits (UH2/UH3) Apply for PAR 14 010 Funding Number: PAR 14 010 Agency: National Institutes of Health Category: Education Health Funding Amount: $125,000 |
| The Palliative Care Research Cooperative (PCRC) Enhancing Sustainability and Building the Science of Palliative Care (R01) Apply for RFA NR 14 003 Funding Number: RFA NR 14 003 Agency: National Institutes of Health Category: Education Health Funding Amount: $350,000 |
| Revision Applications for Research on Genomic Underpinnings of Response to Rehabilitation Interventions (R01) Apply for PAR 14 012 Funding Number: PAR 14 012 Agency: National Institutes of Health Category: Education Health Funding Amount: $100,000 |
| Genomic Underpinnings of Response to Rehabilitation Interventions (R01) Apply for PAR 14 011 Funding Number: PAR 14 011 Agency: National Institutes of Health Category: Education Health Funding Amount: $350,000 |
| Functional Genetics, Epigenetics, and Non coding RNAs in Substance Abuse (R01) Apply for PA 14 014 Funding Number: PA 14 014 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Functional Genetics, Epigenetics, and Non coding RNAs in Substance Abuse (R21) Apply for PA 14 013 Funding Number: PA 14 013 Agency: National Institutes of Health Category: Education Health Funding Amount: $200,000 |
| Public Health Impact of the Changing Policy/Legal Environment for Marijuana (R01) Apply for PAS 14 020 Funding Number: PAS 14 020 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
Grant application guides and resources
It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!
Apply for Grants

Premium leads for funding administrators, grant writers, and loan issuers
Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.
If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.
Subscribe to Leads
Request more information:
Would you like to learn more about this funding opportunity, similar opportunities to "RFA CA 13 010", eligibility, application service, and/or application tips? Submit an inquiry below:
Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.
